vimarsana.com

Latest Breaking News On - Helsinn therapeutics - Page 1 : vimarsana.com

CJC-1295 vs Ipamorelin: A Thorough Evaluation

Pembrolizumab improves outcomes in early-stage resectable lung cancer

CHICAGO — The addition of pembrolizumab to neoadjuvant chemotherapy followed by adjuvant pembrolizumab improved outcomes for patients with early-stage resectable non-small cell lung cancer, according to findings presented at ASCO Annual Meeting.Results of the randomized phase 3 KEYNOTE-671 trial — published simultaneously in The New England Journal of Medicine — showed a

Kazia Therapeutics Ltd appoints Dr John Friend as new CEO

Dr John Friend, chief medical officer (CMO) of Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) will immediately assume the role of chief executive officer.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.